Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?
Multiple Sclerosis Journal · 2026-11 · 32 (13) · 1460-1470
DOI: 10.1177/13524585261476543 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Multiple Sclerosis Journal, online erschienen am 17.08.2026. Verfasst von Maeva Cotinat und 8 weiteren Autor:innen. Beteiligte Einrichtung: CRMBM, CNRS, Aix Marseille University, Marseille, France; CEMEREM, Hôpital Universitaire Timone, APHM, Aix Marseille University, Marseille, France; P…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Chronic Progressive, Disease Progression, Walking Speed. Die Arbeit nennt 34 Literaturangaben. Gefördert von: France Life Imaging.
Abstract (Originalsprache)
Background
Primary progressive multiple sclerosis (PPMS) involves gradual disability accumulation driven by neurodegeneration. Standard outcomes, including the Expanded Disability Status Scale (EDSS) and timed 25-foot walk (T25FW), lack sensitivity to subtle functional changes. Real-life walking speed (RWS) measured with wearable sensors may offer a more responsive marker of progression.
Objectives
In a prospective cohort (2012–2022) at the University Medical Center Hamburg-Eppendorf, adults with PPMS (18–65 years, EDSS ⩽7.0) underwent repeated EDSS, T25FW, Nine-Hole Peg Test (9HPT), and Symbol Digit Modalities Test (SDMT). RWS was recorded using an accelerometer. Disease progression was defined as ⩾20% worsening in T25FW/9HPT, ⩾8-point SDMT decline, EDSS increase (⩾1.0 or ⩾0.5 if >5), or RWS reduction >0.08 m/s.
Results
Among 110 participants (mean age: 52 years; baseline EDSS: 3.5) followed for a median of 3 years, RWS showed a symmetric distribution and declined steadily with increasing EDSS, unlike the skewed T25FW distribution. Annual progression was detected in >30% of participants using RWS, compared with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CRMBM, CNRS, Aix Marseille University, Marseille, France; CEMEREM, Hôpital Universitaire Timone, APHM, Aix Marseille University, Marseille, France; Physical and Rehabilitation Medicine Department, Hôpitaux Sud, APHM, Ai…
- Institut für Neuroimmunologie und Multiple Sklerose, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Sylvia Lawry Centre for Multiple Sclerosis Research, Human Motion Institute, Munich, Germany.
- Sylvia Lawry Centre for Multiple Sclerosis Research, Human Motion Institute, Munich, Germany; Trium Analysis Online GmbH, Research, Munich, Germany.
- CRMBM, CNRS, Aix Marseille University, Marseille, France; CEMEREM, Hôpital Universitaire Timone, APHM, Aix Marseille University, Marseille, France; Service de Neurologie, Pôle de Neurosciences Cliniques, Hôpital de la T…
- Physical and Rehabilitation Medicine Department, Aix Marseille University, APHM, INT, Hôpitaux Sud, Marseille, France; Physical and Rehabilitation Medicine Department, UGECAM Provence-Alpes-Cote d'Azur, Marseille, Franc…
ORCID-Profile: Maeva Cotinat, Christoph Heesen, Ines Boudiaf, Adil Maarouf, Jean-Philippe Ranjeva
Förderung
- France Life Imaging
Zitieren
APA
Cotinat, M., Heesen, C., Boudiaf, I., Lederer, C., Daumer, M., Maarouf, A., Bensoussan, L., Ranjeva, J. P., & Stellmann, J. P. (2026). Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?. Multiple Sclerosis Journal, 32(13), 1460-1470. https://doi.org/10.1177/13524585261476543
Vancouver
Cotinat M, Heesen C, Boudiaf I, Lederer C, Daumer M, Maarouf A, et al. Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?. Multiple Sclerosis Journal. 2026;32(13):1460-1470. doi:10.1177/13524585261476543
BibTeX
@article{Cotinat2026,
author = {Cotinat, Maeva and Heesen, Christoph and Boudiaf, Ines and Lederer, Christian and Daumer, Martin and Maarouf, Adil and Bensoussan, Laurent and Ranjeva, Jean-Philippe and Stellmann, Jan-Patrick},
title = {Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?},
journal = {Multiple Sclerosis Journal},
year = {2026},
volume = {32},
number = {13},
pages = {1460--1470},
doi = {10.1177/13524585261476543}
}
EUVIMED